Co-Diagnostics, Inc. (CODX)
0.1646
-0.03
(-16.74%)
USD |
NASDAQ |
Nov 19, 16:00
0.1398
-0.02
(-15.07%)
After-Hours: 20:00
Co-Diagnostics Enterprise Value : 2.049M for Nov. 19, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 19, 2026 | 2.049M |
| November 18, 2026 | 2.291M |
| November 17, 2026 | 2.278M |
| November 16, 2026 | 2.489M |
| November 13, 2026 | 2.734M |
| November 12, 2026 | 2.815M |
| November 11, 2026 | 2.874M |
| November 10, 2026 | 2.954M |
| November 09, 2026 | 3.175M |
| November 06, 2026 | 2.721M |
| November 05, 2026 | 2.796M |
| November 04, 2026 | 3.484M |
| November 03, 2026 | 3.619M |
| November 02, 2026 | 3.425M |
| October 30, 2026 | 3.522M |
| October 29, 2026 | 3.729M |
| October 28, 2026 | 4.066M |
| October 27, 2026 | 4.267M |
| October 26, 2026 | 4.839M |
| October 23, 2026 | 4.826M |
| October 22, 2026 | 5.004M |
| October 21, 2026 | 5.529M |
| October 20, 2026 | 5.568M |
| October 19, 2026 | 5.704M |
| October 16, 2026 | 5.616M |
| Date | Value |
|---|---|
| October 15, 2026 | 6.062M |
| October 14, 2026 | 6.422M |
| October 13, 2026 | 8.612M |
| October 12, 2026 | 9.960M |
| October 09, 2026 | 9.013M |
| October 08, 2026 | 8.794M |
| October 07, 2026 | 9.013M |
| October 06, 2026 | 9.232M |
| October 05, 2026 | 8.867M |
| October 02, 2026 | 8.721M |
| October 01, 2026 | 8.721M |
| September 30, 2026 | 8.648M |
| September 29, 2026 | 3.37M |
| September 28, 2026 | 3.565M |
| September 25, 2026 | 3.468M |
| September 24, 2026 | 3.760M |
| September 23, 2026 | 3.516M |
| September 22, 2026 | 3.419M |
| September 21, 2026 | 3.077M |
| September 18, 2026 | 2.764M |
| September 17, 2026 | 2.737M |
| September 16, 2026 | 2.740M |
| September 15, 2026 | 3.712M |
| September 14, 2026 | 3.565M |
| September 11, 2026 | 3.614M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Fractyl Health, Inc. | 40.69M |
| Spectral AI, Inc. | 47.56M |
| Omnicell, Inc. | 1.389B |
| Oncolytics Biotech, Inc. | 49.62M |
| Sangamo Therapeutics, Inc. | 36.53M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.306M |
| Revenue (Quarterly) | 0.2829M |
| Total Expenses (Quarterly) | 6.589M |
| EPS Diluted (Quarterly) | -1.005 |
| Gross Profit Margin (Quarterly) | -85.83% |
| Profit Margin (Quarterly) | -2.23K% |
| Earnings Yield | -11.43K% |
| Normalized Earnings Yield | -7593.74 |